TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 285 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2022. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,078,987 | -52.3% | 134,388 | -51.5% | 0.20% | +2.6% |
| Q2 2023 | $4,354,426 | +88.6% | 277,176 | +97.9% | 0.20% | -8.4% |
| Q1 2023 | $2,308,580 | -47.5% | 140,084 | -50.3% | 0.21% | +6.5% |
| Q4 2022 | $4,397,006 | +291.5% | 281,860 | +225.5% | 0.20% | +81.1% |
| Q3 2022 | $1,123,000 | -43.1% | 86,581 | -38.4% | 0.11% | -42.2% |
| Q2 2022 | $1,972,000 | -6.8% | 140,444 | -4.9% | 0.19% | -2.5% |
| Q1 2022 | $2,115,000 | +224.4% | 147,692 | +208.6% | 0.20% | +233.9% |
| Q4 2021 | $652,000 | – | 47,852 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Adelphi Capital LLP | 7,584,930 | $138,046,000 | 26.79% |
| Glenview Capital Management | 15,260,512 | $277,741,000 | 6.37% |
| Paulson & Co. | 11,295,846 | $205,584,000 | 5.34% |
| GMT CAPITAL CORP | 2,871,395 | $52,259,000 | 3.72% |
| MANAGED ASSET PORTFOLIOS, LLC | 966,643 | $17,593,000 | 3.09% |
| TFG Asset Management GP Ltd | 1,443,052 | $26,264,000 | 1.76% |
| Mondrian Investment Partners LTD | 3,274,660 | $58,944,000 | 1.46% |
| Blackcrane Capital, LLC | 35,236 | $641,000 | 1.26% |
| Lumbard & Kellner, LLC | 136,378 | $2,404,000 | 0.95% |
| DAVIDSON INVESTMENT ADVISORS | 509,800 | $9,278,000 | 0.86% |